Hubbry Logo
SuppositorySuppositoryMain
Open search
Suppository
Community hub
Suppository
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Suppository
Suppository
Suppository
View on Wikipedia
from Wikipedia

A suppository is a dosage form used to deliver medications by insertion into a body orifice (any opening in the body), where it dissolves or melts to exert local or systemic effects. There are three types of suppositories, each to insert into a different sections: rectal suppositories into the rectum, vaginal suppositories into the vagina, and urethral suppositories into the urethra of a male.

Suppositories are ideal for infants, elderly individuals and post-operative patients, who are unable to swallow oral medications, and for individuals experiencing severe nausea and/or vomiting.[1][2][3] Suppositories are administered through rectal route to reduce onset time of reaction.

Composition

[edit]

Several different ingredients can be used to form the base of a suppository: cocoa butter or a similar substitute, polyethylene glycol, hydrogels, and glycerinated gelatin. The type of material used depends on the type of suppository, the type of drug, and the conditions in which the suppository will be stored.[4]

Rectal suppositories

[edit]
Glycerin suppositories (laxative)

In 1991, a study on suppository insertion in The Lancet found that the "torpedo" shape helps the device to travel internally, increasing its efficacy.[5] The findings of this single study have been challenged as there is insufficient evidence on which to base clinical practice.[6] Rectal suppositories are intended for localized or systemic action to relieve pain, constipation, irritation, inflammation, nausea and vomiting, fever, migraines, allergies, and sedation.[7][8] If they cause inflammation, chronic use of suppositories may cause rectal stricture,[9] but overall this is a safe method of drug delivery.[10]

Four 500 mg paracetamol suppositories

Urethral suppositories

[edit]

Alprostadil pellets are urethral suppositories used for the treatment of severe erectile dysfunction (impotence). They are marketed under the name Muse in the United States.[11] Its use has diminished since the development of oral impotence medications.

See also

[edit]
Wikimedia Commons has media related to:
Suppository (category)

Notes

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Suppository

View on Grokipedia
from Grokipedia
A suppository is a solid of designed to be inserted into the , , or , where it melts or dissolves at body temperature to release the active for local treatment or systemic absorption through the mucosal lining. Suppositories offer an alternative route of delivery when is impractical, such as during , , or in pediatric and geriatric patients unable to pills. The rectal route, the most common, leverages the thin rectal wall and rich supply for efficient absorption while partially avoiding first-pass in the liver, potentially enhancing for certain . Vaginal suppositories target gynecological conditions like infections or , while urethral types address specific issues such as . Common uses include relieving with stimulant laxatives like , reducing inflammation in or with corticosteroids such as , managing pain or fever with analgesics like acetaminophen, and controlling with antiemetics like . These formulations typically consist of the active pharmaceutical ingredient dispersed or dissolved in a suppository base, which must be biocompatible, non-irritating, and capable of melting between 30–37°C. Traditional bases include lipophilic materials like or hydrogenated vegetable oils (e.g., Witepsol), which melt readily, and hydrophilic options like (PEG) or glycerinated , which dissolve in bodily fluids. Additives such as may improve drug release or stability. Suppositories are shaped as cones, ovoids, or cylinders for easy insertion, often using applicators for precision and comfort. Historically, suppositories date back to ancient civilizations, where natural bases like , , , or horn were impregnated with medicinals for rectal use; modern versions emerged in the with cocoa butter formulations, while glycerin and bases were introduced in the late . Despite their , potential drawbacks include local , variable absorption influenced by or base composition, and patient discomfort, necessitating proper technique—such as remaining on one's side post-insertion for rectal types—to optimize effectiveness.

Introduction

Definition

A suppository is a medicated solid or semi-solid designed for insertion into the , , or , where it melts or dissolves at body temperature to release the active for local or systemic absorption through the mucous membranes. These are typically composed of an active pharmaceutical ingredient incorporated into a base, such as , glycerinated , or , which facilitates release. Key characteristics include a compact , often 2–3 cm in length for rectal suppositories, and a torpedo-shaped or tapered design to ease insertion and minimize discomfort. They are particularly useful when is impractical, such as in cases of , , or pediatric and geriatric patients unable to swallow. In contrast to tablets or capsules, suppositories bypass the , avoiding first-pass and enabling direct absorption via the rectal or vaginal mucosa for potentially faster onset or targeted delivery. The mechanism relies on the base softening, melting, or dispersing upon exposure to (around 37°C), allowing the to diffuse into surrounding tissues or enter the systemic circulation.

History

The use of suppositories dates back to ancient civilizations, with evidence from Egyptian medical texts around 1500 BCE describing rectal and vaginal insertions made from mixtures of , animal fats, and extracts to treat various ailments, as documented in the . These early formulations served both therapeutic and emetic purposes, often incorporating natural substances like dung or for contraceptive effects. In and , medical preparations evolved to include wax bases, valued for their moldability and stability in delivering medicinals. During the medieval period, Arab physicians advanced suppository formulations through systematic documentation and compounding. In the 11th century, Ibn Sina (Avicenna) contributed to the development of compound drugs, including for rectal and vaginal use, in his , influencing European pharmacy. By the and into the 18th century, European apothecaries refined these methods, though significant material innovations occurred later; emerged as a preferred base in the early , first recorded in 1841 for opium suppositories due to its low melting point near body temperature. The 19th and early 20th centuries marked industrialization and regulatory milestones for suppositories. Glycerin-based suppositories, introduced around the 1860s by firms like John Wyeth & Brother (founded 1861), gained popularity as non-medicated laxatives, leveraging glycerin's hygroscopic properties to stimulate evacuation without additional drugs. Synthetic alternatives followed, with (PEG) bases developed in the 1940s as water-soluble vehicles offering customizable melting points and improved stability over traditional fats. The U.S. Food, Drug, and Cosmetic Act of 1938 formally classified suppositories as pharmaceutical drugs, mandating safety and efficacy standards that spurred advancements. In the , suppository design has focused on enhanced and patient compliance. Controlled-release formulations, such as hollow-type suppositories introduced in the , allowed encapsulation of liquids or gels within a solid shell for sustained , reducing dosing frequency. Post-2000 innovations include mucoadhesive suppositories incorporating polymers like or carbopol to prolong mucosal contact and improve retention, as demonstrated in studies on thermosensitive gels for localized . From 2020 onward, advancements have included sustained-release suppository formulations and rectal delivery systems for antibiotics like to improve . These developments reflect a shift toward targeted, patient-friendly rectal and vaginal in contemporary .

Types

Rectal Suppositories

Rectal suppositories are solid specifically designed for insertion into the , typically featuring a or with a rounded tip for ease of insertion and a tapered end to minimize discomfort. These suppositories are generally cylindrical or conical, measuring about 2-3 cm in length and weighing approximately 2 grams for use, while pediatric versions are smaller, around 1 gram. The and are optimized to conform to the rectal , allowing the suppository to be positioned effectively within the rectal canal. The positioning of rectal suppositories takes into account the rectum's vascular to achieve desired therapeutic effects. For systemic absorption, suppositories are placed in the lower , where the inferior and middle rectal veins predominate, draining directly into the systemic circulation and bypassing the liver. In contrast, placement higher in the targets the superior rectal vein, which leads to the portal system, favoring local effects within the rectal mucosa. This strategic positioning influences the balance between local and systemic action, with the lower enabling partial avoidance of hepatic first-pass —approximately 50% of absorbed evades full liver processing via the inferior and middle rectal veins. Common indications for rectal suppositories include treatment of with laxatives such as , which stimulates bowel movements; antiemetic therapy with to manage and ; and analgesic relief with indomethacin for moderate to severe associated with conditions like or . These formulations are particularly advantageous in , where they address fever, postoperative , and migraines without relying on oral intake, and in , supporting management of or when swallowing is impaired due to age-related issues. For constipation relief in infants, common over-the-counter options include Quality Choice Infant Glycerin Suppositories (available in 25-unit bottles) and generic versions from retailers such as Walgreens, CVS, Walmart, and Target. To ensure retention and efficacy, rectal suppositories are formulated to melt at body temperature, around 37°C, allowing them to soften and release the upon contact with rectal mucosa. For instance, glycerin-based suppositories function as hyperosmotic agents, drawing water into the to promote evacuation without relying on for primary action, making them suitable for rapid in both pediatric and adult populations.

Vaginal Suppositories

Vaginal suppositories are specifically formulated for insertion into the , where they dissolve or disintegrate to release active ingredients directly onto the mucosal lining. These suppositories are typically oval, egg-shaped, bullet, or cone-shaped to enhance comfort and facilitate smooth insertion, distinguishing them from the more cylindrical rectal forms. Their size is generally smaller than rectal suppositories, weighing between 1 and 2 grams to minimize discomfort in the vaginal canal. For optimal efficacy, vaginal suppositories are inserted deep into the , ideally into the posterior fornix—a recess at the back of the —to ensure close contact with the vaginal mucosa and promote localized drug distribution. This positioning leverages the 's anatomical structure, including its rugose walls and self-lubricating environment, to support drug release while accommodating the natural movements of daily activities. The design prioritizes and ease of self-administration, often using applicators for precise placement without requiring a healthcare provider. These suppositories serve key roles in gynecological care, primarily delivering medications for local treatment of vaginal infections and hormonal support. agents like clotrimazole are commonly used to treat vulvovaginal (yeast infections) by targeting fungal overgrowth on the vaginal mucosa. Hormonal therapies, such as progesterone suppositories, provide support for fertility treatments by supplementing progesterone levels to aid embryo implantation. Antibacterial options, including , address bacterial vaginosis (BV) by disrupting anaerobic bacterial flora responsible for the condition. The absorption profile of vaginal suppositories emphasizes local action, with the primarily exerting effects on the vaginal tissues rather than widespread systemic circulation, thereby reducing potential side effects. This localized delivery is influenced by the vagina's rich vascular network but limited by its epithelial barrier, resulting in minimal systemic uptake for most formulations. Bases used in these suppositories are often -sensitive to align with the vagina's naturally acidic environment (pH 3.5-4.5), which is maintained by lactobacilli and helps inhibit pathogenic growth while optimizing drug stability and release. Vaginal suppositories gained prominence in the 20th century as targeted therapies for women's reproductive health issues, evolving from early 20th-century formulations for infection control and hygiene to more specialized uses in hormonal and antimicrobial treatments. By the mid-century, they were widely marketed for conditions like vaginal infections and became staples in gynecological practice, reflecting advances in pharmaceutical compounding for female-specific needs. Contemporary innovations include bioadhesive formulations, which incorporate polymers to adhere to the vaginal mucosa and prevent premature expulsion due to gravitational or muscular forces, thereby extending residence time and improving therapeutic outcomes.

Urethral Suppositories

Urethral suppositories are specialized, small pellet-like formulations engineered for insertion into the male , typically measuring 1.4 mm in diameter and 3 to 6 in length to facilitate passage through the narrow urethral meatus without causing significant trauma. Weighing less than 1 gram, these fragile, often lubricated devices dissolve rapidly upon contact with the urethral mucosa, prioritizing minimal irritation to the sensitive tissues. The primary application of urethral suppositories is in treating erectile dysfunction, exemplified by the alprostadil-based MUSE system, which delivered the vasodilator directly to penile tissues for erection induction. Approved by the FDA in 1996, MUSE represented a key intraurethral option until its discontinuation by the manufacturer in June 2024; as of 2025, urethral suppositories are rarely prescribed due to limited availability and the preference for alternative therapies like injections or oral medications. Historical or rare uses extended to urinary antiseptics, such as protargol bougies for gonococcal urethritis in the early 20th century. In diagnostics, such formulations have occasionally aided urethral assessment, though modern applications remain niche. Insertion involved advancing the suppository 3 to 5 cm into the using a dedicated applicator, targeting the fossa navicularis for optimal drug release. Absorption occurred swiftly through the penile vasculature, particularly via the corpus spongiosum to the corpora cavernosa, achieving peak effects within 10 minutes due to the rich mucosal blood supply. This route is inherently limited to owing to anatomical differences, with the being shorter and less suitable for such delivery. Due to associated discomfort, including penile pain, urethral burning, and minor risks that could lead to trauma if mishandled, urethral suppositories are less commonly prescribed compared to other therapies. FDA-approved examples, like intraurethral alprostadil in the , underscored their regulated status but highlighted the need for careful selection to mitigate these challenges.

Formulation

Bases and Excipients

Suppository bases form the primary structural component of these , providing a solid matrix that melts, softens, or dissolves upon administration to release the active pharmaceutical ingredient (). They are broadly classified into lipophilic, hydrophilic, and synthetic types, each selected based on desired release profiles and compatibility with the drug. Lipophilic bases, such as (theobroma oil), are fats that melt at body temperature, typically in the range of 33–35°C, but become brittle below 25°C due to their solid consistency at . These bases facilitate sustained drug release by partitioning the into mucosal fluids after , though their polymorphism—existing in multiple forms with varying melting points (e.g., unstable forms at 18–28°C)—can lead to instability if not properly managed during storage. Hydrophilic bases, exemplified by glycerin- mixtures (typically 70% glycerin, 20% , and 10% water), are water-soluble and dissolve or disperse in rectal or vaginal fluids, enabling drug release through dissolution in bodily fluids, with rates influenced by drug and base type. These bases absorb from surrounding tissues, promoting gradual dissolution over time, which suits applications requiring prolonged local action, such as in vaginal suppositories. Synthetic bases, often (PEG) polymers like mixtures of PEG 1000 and 3350, offer versatility with customizable melting points (typically 40–50°C through blending different molecular weights) and enhanced stability, avoiding the rancidity issues of natural fats. PEG bases are , non-irritating, and compatible with both hydrophilic and lipophilic APIs, dissolving slowly (30–40 minutes) in bodily fluids for controlled release. Excipients in suppositories augment base functionality without contributing therapeutically, including like , which improve dispersion and wetting in the base for uniform release. Preservatives such as prevent microbial growth in moisture-sensitive formulations, particularly those with hydrophilic bases. Antioxidants, for instance (BHT), inhibit oxidation in lipophilic bases prone to rancidity, extending . Selection of bases and excipients hinges on compatibility, ensuring and to avoid degradation or . Release rate is another key criterion: lipophilic bases support sustained delivery by slowing into aqueous environments, while hydrophilic bases facilitate release through dissolution, with rates depending on the drug's physicochemical properties and compatibility with the base. Patient-specific factors, such as allergies to cocoa-derived components, also influence choices, favoring synthetic alternatives like PEG for broader tolerability. Stability challenges, particularly in lipophilic bases, arise from fat polymorphism, where phase transitions during storage can alter behavior and drug release consistency. To mitigate this, suppositories are stored below 25°C to maintain the stable beta polymorphic form and prevent softening or blooming.

Manufacturing Processes

The fusion method, also known as melt molding, is the primary industrial technique for suppository production, suitable for heat-stable active pharmaceutical ingredients. The process begins by the suppository base—such as synthetic or —at a controlled range of 40–50°C to ensure complete without degradation, followed by the incorporation of the through dispersion or dissolution using mechanical stirring. The homogeneous mixture is then poured into lubricated, chilled metal or molds under to eliminate air bubbles, and the assembly is cooled to ambient or refrigerated to solidify the suppositories, which are subsequently demolded, inspected, and packaged. This method allows for high-volume scalability with automated pouring and cooling systems. The hand-rolling method represents an archaic, manual approach primarily employed in pharmacies for small-batch, personalized preparations. It involves softening the base material, typically , to a pliable state, forming a pellet, and manually rolling the base around the pellet to create a cylindrical shape, which is then cut to the desired length and rounded at the ends. While simple and requiring minimal equipment, this technique is labor-intensive, prone to inconsistencies in shape and drug distribution, and largely supplanted by mechanized processes in modern practice. Compression molding offers a cold-process alternative ideal for moisture-sensitive or drugs, avoiding the risks associated with heating. The base and drug are finely powdered, blended with binders if necessary to promote , and the mixture is forced under into molds using a compression press or suppository , forming solid units that are ejected upon hardening at . This method ensures preservation of drug stability but demands precise control of and moisture content to achieve uniform density. Quality control measures are integral to suppository to verify consistency, potency, and across batches. Uniformity of content, as per USP <905>, assesses the distribution in at least 30 units, requiring an acceptance value of no more than 15 and individual contents within 85–115% of the labeled amount for passing criteria. Weight variation testing, conducted on 20 suppositories, permits no more than 2 to deviate from the average by over 5% and none by more than 10%, ensuring reproducible dosing. Disintegration testing in simulated rectal fluid at 37°C evaluates breakdown time, typically 15–30 minutes for lipophilic bases, with all units required to pass through a 2.0 mm sieve within 60 minutes per USP guidelines to confirm adequate drug release. For urethral and vaginal suppositories, sterility assurance via USP <71> microbial limits testing is essential to mitigate infection risks, involving membrane filtration and incubation for bacterial and fungal detection. Modern manufacturing has incorporated automated extrusion systems for enhanced precision and scalability, particularly through semi-solid techniques that deposit base-drug mixtures layer-by-layer into custom molds, enabling personalized dosing and complex geometries since the early . Additionally, post-2010 research has advanced solvent-free drug loading using supercritical CO2 impregnation, where the fluid phase facilitates uniform drug incorporation into polymer-based matrices under mild conditions, reducing processing solvents and improving without thermal stress.

Administration

Insertion Methods

Proper preparation is essential for safe and effective suppository insertion across all routes to minimize infection risk and ensure comfort. Caregivers or patients should begin by washing hands thoroughly with soap and water, followed by donning disposable gloves to maintain hygiene. A water-soluble , such as , should be applied to the suppository tip or applicator to ease insertion and prevent tissue irritation; petroleum-based products like are unsuitable as they may impede dissolution. Patients are advised to empty the bowel or beforehand if applicable, and privacy should be provided during the procedure. For rectal suppositories, the patient assumes a left lateral recumbent position with the upper flexed toward the chest to relax the anal and facilitate access. The tapered or pointed end of the suppository is gently inserted first using a gloved finger, directed toward the umbilicus along the rectal wall, approximately 2.5 to 5 cm (1 to 2 inches) in adults to ensure it passes the internal for optimal retention. In children, a smaller pediatric suppository is used, inserted only 1.25 to 2.5 cm (0.5 to 1 inch) to match anatomical proportions. The patient should remain lying down for 15 to 30 minutes post-insertion to allow the base to melt and promote absorption, avoiding immediate bowel movements which can expel the suppository if it occurred recently. Vaginal suppository insertion typically occurs with the patient in a , knees flexed and drawn up to expose the . After performing perineal , the rounded end of the suppository is lubricated and inserted along the posterior vaginal wall using the or a provided applicator, advancing it as far as comfortable, usually 5 to 10 cm (2 to 4 inches). To minimize leakage and enhance retention, the patient remains for 5 to 10 minutes after insertion; administration at is often recommended for overnight absorption, particularly in treatment regimens. Urethral suppositories, such as alprostadil pellets (e.g., the discontinued system) for , require immediately prior to insertion to cleanse the . The is straightened to full length, and the applicator stem—containing the pellet—is gently inserted up to its collar (approximately 3 cm) into the urethral meatus before depressing the button to release the medication. The is then held upright and rolled gently between the hands for 5 to 10 seconds to distribute and initiate dissolution of the pellet. This method is specific to proprietary devices like (discontinued in the in 2024), and professional instruction is advised for initial use.

Pharmacokinetics and Absorption

Suppositories release active pharmaceutical ingredients through several mechanisms depending on the base composition. In lipophilic bases, such as those composed of or glycerin esters, the base melts at body temperature, typically within 5-15 minutes, allowing the to be liberated and come into contact with the mucosal surface for absorption. Hydrophilic bases, like , promote release via dissolution in the moist rectal or vaginal environment, often resulting in faster onset compared to processes. Additionally, of the through the base matrix contributes to release, particularly for suspended particles, where the partitions into the surrounding fluids before absorption. Absorption from suppositories occurs primarily through the mucosal linings of the administration site, with varying by route. Rectal suppositories achieve variable systemic due to partial avoidance of hepatic first-pass , as the lower rectal veins drain directly into the systemic circulation while upper veins connect to the portal system. Vaginal suppositories prioritize local effects, with systemic uptake typically ranging from 10-30%, as seen with clindamycin where absorption averaged 30% following . Urethral suppositories, such as those containing alprostadil, enable rapid absorption, with approximately 80% of the dose absorbed within 10 minutes via the urethral mucosa. Several factors influence the and absorption efficiency of suppositories. The base type plays a key role; lipophilic bases provide slower, more sustained release compared to hydrophilic ones, affecting the rate of drug availability at the absorption site. of the drug is critical, with micronized or smaller particles enhancing dissolution and absorption rates by increasing surface area for interaction with mucosal fluids. Interactions with and can alter absorption; the rectal (around 7-8) and layer may ionize drugs or hinder , while variations can lead to or reduced uptake. generally offers superior over oral routes for drugs prone to first-pass , bypassing a significant portion of hepatic processing. Bioavailability from suppositories can vary considerably, as illustrated by acetaminophen, where shows lower (typically 20-50%) and higher inter-individual variability compared to oral dosing (70-90%). Factors like , patient movement, or incomplete retention can result in up to 30% loss of the dose, further impacting absorption and therapeutic efficacy.

Clinical Applications

Therapeutic Uses

Suppositories are employed across various medical conditions, leveraging their ability to deliver drugs locally or systemically via rectal, vaginal, or urethral routes, with applications supported by clinical trials and guidelines. Rectal suppositories are commonly used for relief, where glycerin acts as an osmotic to draw water into the and stimulate evacuation, typically within 15 to 60 minutes. For infants, smaller-sized glycerin suppositories are available over-the-counter, with common brands including Pedia-Lax and Fleet, as well as generic options such as Quality Choice (25-unit bottle) from retailers like Walgreens, CVS, Walmart, and Target. suppositories function as stimulants by irritating the rectal mucosa to promote , showing efficacy in chronic with level 4 evidence from systematic reviews. For and , particularly in or postoperative settings, rectal ondansetron suppositories provide effective prophylaxis, equivalent to intravenous administration in preventing emesis induced by . In scenarios where oral intake is contraindicated, such as fever or in children or debilitated patients, rectal ibuprofen suppositories reduce temperature and alleviate discomfort comparably to oral forms, with pilot studies confirming similar safety and efficacy profiles. Vaginal suppositories target gynecological conditions, including infections like vulvovaginal candidiasis, where miconazole (200 mg suppository for 3 days or 1,200 mg for 1 day) is recommended by CDC guidelines for symptom relief and mycotic eradication. Hormonal therapies utilize vaginal progesterone suppositories for support in assisted reproduction and to potentially prevent in women with recurrent loss, though a large RCT found no significant increase in live birth rates despite reduced early losses in some subgroups. For , dinoprostone vaginal inserts (10 mg) promote cervical ripening and , with meta-analyses supporting their efficacy in reducing cesarean rates when compared to , particularly in women with unfavorable cervices. Urethral suppositories have more limited applications, primarily for , where alprostadil (125–1,000 mcg) induces via with an onset of 10 to 30 minutes before intercourse, as evidenced by multicenter trials showing successful intercourse in up to 56% of uses. In special populations, suppositories offer advantages for those unable to take oral medications. In , rectal paracetamol (acetaminophen) suppositories (25 mg/kg) provide effective fever reduction in infants, with pharmacokinetic studies in children aged 9 weeks to 11 years demonstrating reliable absorption after repeated dosing post-surgery. For , rectal suppositories manage terminal symptoms like pain and associated , with small studies indicating faster onset and reduced emetic side effects compared to oral routes. Rectal suppositories (0.5 mg/kg during fever) prevent recurrent febrile seizures in children, supported by 1990s RCTs showing a 40% reduction in recurrence rates versus . Emerging applications include antiviral therapy, such as experimental vaginal acyclovir formulations for prevention of due to HSV.

Contraindications and Precautions

Suppositories are contraindicated in patients with active or severe for rectal administration, as insertion may exacerbate bleeding or cause further irritation to inflamed tissues. Similarly, vaginal suppositories should be avoided in cases of undiagnosed vaginal infections, open sores, or active sexually transmitted infections to prevent worsening of the condition or introduction of contaminants. For urethral suppositories, absolute contraindications include urethral strictures, , or any urethral infection, due to the risk of trauma, obstruction, or spread of infection. Relative precautions apply in situations such as known allergies to suppository base components, including or other excipients, which may lead to local reactions. Patients with impaired mobility may require assistance with insertion to ensure proper placement and avoid incomplete administration. In , vaginal suppositories containing hormones necessitate close monitoring for potential effects on fetal development, and their use should be limited unless benefits outweigh risks. Type-specific risks include an increased potential for in elderly patients during insertion, particularly those with weakened muscles. Vaginal suppositories often result in leakage, which can cause discomfort or mess but is generally not harmful if managed with protective liners. Urethral administration of alprostadil carries a risk of in 1-5% of cases, requiring immediate medical intervention to prevent tissue damage. Monitoring is essential for patients with hepatic impairment, as rectal suppositories may still undergo partial first-pass metabolism, potentially necessitating dose reductions to avoid accumulation. Pediatric dosing for rectal suppositories is weight-based (e.g., 10-15 mg/kg for acetaminophen), to account for differences in absorption and body size. Guidelines from the (USP) emphasize sterile production for suppositories intended for sensitive areas like the or to minimize infection risks, with separate facilities for sterile compounding under USP <797>. The (WHO) similarly recommends adherence to good manufacturing practices for all rectal and vaginal formulations to ensure sterility in vulnerable mucosal sites.

Advantages and Considerations

Benefits Over Other Routes

Suppositories offer significant advantages over in patients experiencing gastrointestinal disturbances, such as , , or , as well as in unconscious or postoperative individuals where oral intake is impractical. For instance, rectal suppositories provide effective analgesia and effects in postoperative settings without relying on the oral route. This route ensures even when is not feasible, making it a reliable alternative for emergency or critical care scenarios. Rectal suppositories can enhance by partially bypassing hepatic first-pass , with approximately 50% of the absorbed drug entering systemic circulation directly via the inferior and middle rectal veins. This partial avoidance reduces presystemic drug loss compared to , where nearly all of the drug undergoes extensive liver . Additionally, for certain medications, rectal delivery achieves faster , often within 15-30 minutes, versus the typical or more for oral forms, due to direct mucosal absorption. Vaginal suppositories enable high local concentrations at the site of action, often exceeding plasma levels by several fold, which is particularly beneficial for treatments targeting vulvovaginal . This targeted delivery minimizes systemic exposure and associated side effects, unlike oral antifungals that distribute broadly and may require higher doses to achieve therapeutic vaginal levels. In pediatric populations, suppositories improve patient compliance as a non-invasive option compared to injections, with studies showing high acceptance rates among parents for use in . Children often tolerate better than needles, reducing distress and facilitating treatment in outpatient or home settings. Certain suppository formulations demonstrate stability in tropical climates; for example, specific PEG mixtures can maintain integrity at temperatures exceeding 50°C, avoiding degradation issues common in liquid oral preparations. For chronic conditions like , they offer a cost-effective solution due to simple and long , promoting adherence in resource-limited environments.

Side Effects and Limitations

Suppositories can cause various common side effects depending on the and . Rectal suppositories, particularly those containing stimulant laxatives, may lead to and tenesmus in some users, manifesting as discomfort or an urge to defecate shortly after insertion. Vaginal suppositories occasionally result in discharge or itching, often linked to the base or excipients disrupting local mucosal balance. Urethral suppositories, such as those with alprostadil (e.g., , discontinued in the U.S. in 2024), are associated with burning sensations in about 12% of cases, alongside minor bleeding or spotting. Serious adverse effects, though uncommon, include allergic reactions to suppository bases like or , which can rarely progress to in sensitized individuals. Additionally, suppositories may migrate or be expelled prematurely, particularly in patients, compromising efficacy by reducing contact time with the mucosa. Several limitations hinder widespread suppository use. Absorption variability is a key issue, influenced by factors such as fecal matter in the or menstrual blood in the , leading to inconsistent . Patient discomfort and associated stigma contribute to low adherence due to or perceived invasiveness. Furthermore, suppositories are unsuitable for many drugs with poor in lipophilic or hydrophilic bases, limiting their formulation to compounds that dissolve readily at body temperature. Storage poses practical challenges, as bases like melt above 30°C, necessitating cool conditions to maintain integrity and prevent deformation. Shelf life varies depending on the , , and storage conditions, after which stability and potency may decline. In some regions, cultural taboos surrounding rectal or vaginal insertion contribute to underutilization despite proven . Ongoing in the 2020s focuses on controlled-release suppositories to address absorption inconsistencies and improve patient acceptability.

References

  1. https://www.merckmanuals.com/home/drugs/administration-and-kinetics-of-drugs/drug-administration
  2. https://www.mayoclinic.org/drugs-supplements/alprostadil-urethral-route/description/drg-20138507
  3. https://www.webmd.com/digestive-disorders/suppositories-how-to-use
  4. https://www.mayoclinic.org/drugs-supplements/mesalamine-rectal-route/description/drg-20068210
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC6805701/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC6123880/
  7. https://www.ncbi.nlm.nih.gov/books/NBK593215/
  8. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/suppository
  9. https://pharmlabs.unc.edu/labexercises/compounding/suppositories/
  10. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/suppository-base
  11. https://muvs.org/media/pdf/contraception-through-the-ages.pdf
  12. https://www.sju.edu/pharmacymuseum/exhibitions/past
  13. https://www.britannica.com/science/polyethylene-glycol
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC9609333/
  15. https://www.sciencedirect.com/science/article/abs/pii/S0378517302002326
  16. https://www.researchgate.net/publication/395775404_Development_and_characterization_of_suppository_formulation_for_rectal_delivery_of_clarithromycin
  17. https://www.ualberta.ca/en/pharmacy/media-library/research/ddic/documents/suppo.pdf
  18. https://quizlet.com/160341127/suppositories-inserts-flash-cards/
  19. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/rectal-absorption
  20. https://www.mayoclinic.org/diseases-conditions/constipation-in-children/diagnosis-treatment/drc-20354248
  21. https://www.walmart.com/ip/Quality-Choice-Infants-Glycerin-Suppositories-Laxative-Relief-25-Ct-Each/792240057
  22. https://medlineplus.gov/druginfo/meds/a611051.html
  23. https://www.mayoclinic.org/drugs-supplements/promethazine-rectal-route/description/drg-20070623
  24. https://www.mayoclinic.org/drugs-supplements/indomethacin-rectal-route/description/drg-20069803
  25. https://www.sciencedirect.com/science/article/pii/S0169409X14001069
  26. https://www.medicalnewstoday.com/articles/suppository-for-constipation
  27. https://healthy.kaiserpermanente.org/health-wellness/drug-encyclopedia/drug.glycerin-adult-rectal-suppository.467736
  28. https://pharmlabs.unc.edu/wp-storage/labs/suppository/routes.htm
  29. https://pubmed.ncbi.nlm.nih.gov/483950/
  30. https://medlineplus.gov/druginfo/meds/a682753.html
  31. https://www.mayoclinic.org/drugs-supplements/metronidazole-vaginal-route/description/drg-20064738
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC8232205/
  33. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/vagina-ph
  34. https://americanhistory.si.edu/collections/object-groups/health-hygiene-and-beauty/feminine-hygiene-products
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC4190532/
  36. https://fda.report/DailyMed/4c55f3f9-c4cf-11df-851a-0800200c9a66
  37. https://mobile.fpnotebook.com/Uro/Pharm/IntrthrlAlprstdl.htm
  38. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020700s032lbl.pdf
  39. https://www.drugs.com/availability/generic-muse.html
  40. https://pharsight.greyb.com/drug/muse-patent-expiration
  41. https://www.news-medical.net/health/Gonorrhea-History.aspx
  42. https://www.rxlist.com/muse-drug.htm
  43. https://go.drugbank.com/drugs/DB00770
  44. https://pharmlabs.unc.edu/wp-storage/labs/suppository/bases.htm
  45. https://basicmedicalkey.com/24-suppository-bases/
  46. https://www.pccarx.com/Blog/choosing-the-right-suppository-base
  47. https://www.pccarx.com/Blog/the-role-of-surfactants-in-compounded-preparations
  48. https://www.padagis.com/wp-content/uploads/2021/10/Sec-Artem-18.1.pdf
  49. https://www.formulationbio.com/products/antioxidants.html
  50. https://vicihealthsciences.com/suppository-formulation-development/
  51. https://gsconlinepress.com/journals/gscbps/sites/default/files/GSCBPS-2023-0429.pdf
  52. https://pubmed.ncbi.nlm.nih.gov/7400945/
  53. https://www.pharmaguideline.com/2021/10/methods-of-preparation-displacement-value-calculation-evaluation-of-suppositories.html
  54. https://pharmlabs.unc.edu/wp-storage/labs/suppository/prep.htm
  55. https://iipseries.org/assets/docupload/rsl202447EE670C367D99D.pdf
  56. https://www.usp.org/sites/default/files/usp/document/harmonization/excipients/m99694.pdf
  57. https://www.mjpms.in/articles/a-discussion-on-quality-control-of-suppositories.pdf
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC10663909/
  59. https://www.usp.org/sites/default/files/usp/document/harmonization/gen-method/q0304_stage_6_monograph_25_feb_2011.pdf
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC9785904/
  61. https://www.sciencedirect.com/science/article/abs/pii/S0896844620301431
  62. https://www.safemedication.com/how-to-use-medication/rectal-suppositories
  63. https://www.healthline.com/health/general-use/how-to-use-rectal-suppositories
  64. https://www.ncbi.nlm.nih.gov/books/NBK593196/
  65. https://www.plymouthhospitals.nhs.uk/display-pil/pil-suppositories-how-to-use-them--6294/
  66. https://www.healthline.com/health/general-use/how-to-use-vaginal-suppositories
  67. https://www.researchgate.net/publication/287790285_Drug_delivery_on_rectal_absorption_Suppositories
  68. https://pharmaceutical-journal.com/article/feature/exploring-the-unconventional-routes-rectal-and-vaginal-dosage-formulations
  69. https://accp1.onlinelibrary.wiley.com/doi/10.1177/00912709922008461
  70. https://pubmed.ncbi.nlm.nih.gov/12879108/
  71. https://pubmed.ncbi.nlm.nih.gov/6548636/
  72. https://jamanetwork.com/journals/jamapediatrics/fullarticle/379547
  73. https://www.webmd.com/drugs/2/drug-56185/adult-suppositories-rectal/details
  74. https://www.ncbi.nlm.nih.gov/books/NBK547733/
  75. https://www.sciencedirect.com/science/article/abs/pii/S1368837597000067
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC9905032/
  77. https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm
  78. https://www.nejm.org/doi/full/10.1056/NEJMoa1504927
  79. https://www.ajog.org/article/S0002-9378%2823%2900081-9/fulltext
  80. https://pubmed.ncbi.nlm.nih.gov/11064607/
  81. https://ascopubs.org/doi/10.1200/JCO.2001.19.9.2542
  82. https://www.nejm.org/doi/full/10.1056/NEJM199307083290202
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC7281190/
  84. https://opentextbc.ca/clinicalskills/chapter/6-4-rectal-and-vaginal-medications/
  85. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7743779d-1e42-4b23-bde5-0d77fe95bb2b
  86. https://medlineplus.gov/druginfo/meds/a623013.html
  87. https://www.medicalnewstoday.com/articles/322908
  88. https://www.ncbi.nlm.nih.gov/books/NBK542217/
  89. https://www.fda.gov/media/71311/download
  90. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf
  91. https://www.usp.org/compounding/general-chapter-797
  92. https://www.who.int/publications/m/item/trs1044-annex2
  93. https://pubmed.ncbi.nlm.nih.gov/6126289/
  94. https://shands-professionals.sites.medinfo.ufl.edu/files/2011/11/0513.pdf
  95. https://www.macycatheter.com/wp-content/uploads/2022/07/Medication-Fluid-Reference.pdf
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC4757629/
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC10209754/
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC7150883/
  99. https://www.goodrx.com/muse/what-is
  100. https://iipseries.org/assets/docupload/rsl202403CF743043572E3.pdf
  101. https://pmc.ncbi.nlm.nih.gov/articles/PMC10041531/
  102. https://www.pharmaguideline.com/2021/10/definition-types-advantages-and-disadvantages-of-suppositories.html
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.